Ask an Expert is a free question-and-answer service about breast cancer and breast health that is available on weekends. If you'd like to ask a question or comment, please visit us again on Saturday or Sunday. In the meantime, please search the existing topics using the search tool at the top of the page. It's quite possible that one of our many existing topics already addresses your question.
If you would like a consultation with a breast specialist at the Johns Hopkins Avon Foundation Breast Center, call 443-778-2778. It is possible to get an appointment for a second opinion within a few days of contacting us.
We hope you find the information helpful!
|Forum||Questions||Ask a Question|
|LCIS - Lobular Carcinoma In Situ
Questions about lobular carcinoma in situ.
|Asked||Publicly Submitted Question|
|4/13/2012||I am 64 years old and was on HT for 14 years. I was diagnosed with lobular breast cancer. Had a lumpectomy March 6, 2cm, stage 2, grade 1, er+/pr+ Hr2-. Margins were clear and node was clean. My oncotype DX test came back with a score of 18. My surgeon said "yea, no chemo, just radiation and arimidex for 5 years. I was happy! My oncologist said I had an 89% change my cancer would not return. If I did chemo my chances would rise to 91%. With that 2% percentage I would like to opt "no chemo" and want to make sure I am making the best decision for my situation. My oncologist say's the decision is totally up to me since since I am in a "safe zone." I was hoping she would have made that decision for me - would be so much easier to live with. If the chemo was going to put me in a higher percentage bracket I could see doing it. I'm confused and scared.|
|Replied||JHU's Breast Center Reply|
|4/13/2012||Thank you for turning to the Johns Hopkins Breast Center with your question, and you certainly raise a good question. The oncotype score in the intermediate range does create decision making dilemma of should "I or shouldn't I"? Chemotherapy itself is not with out risks and side effects, and a 2% benefit is not significant benefit. And an indeterminate score is not really a 'safe zone', its just a score that does not overwhelming indicate benefit of chemo based on risk of recurrence. Hope this helps and best wishes.|
Please note: This service is not intended to provide primary medical advice concerning specific medical care or treatment. Ask an Expert is a free service operated by health care professionals at the Johns Hopkins Avon Foundation Breast Center. Due to the volume of questions and their complexity, there are times when medical oncologists, surgeons, radiation oncologists or oncology nurses are consulted for their input. These individuals volunteer their time for this service and will respond as soon as they are able. Please do not post or send the same question to us in multiple locations or categories.